Skip to Content

Basiliximab

In the US, Basiliximab (basiliximab systemic) is a member of the drug class interleukin inhibitors and is used to treat Organ Transplant, Rejection Prophylaxis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA09,L04AC02

CAS registry number (Chemical Abstracts Service)

0179045-86-4

Chemical Formula

C6378-H9844-N1698-O1997-S48

Therapeutic Categories

Immunosuppressant

Monoclonal antibody

Chemical Name

Immunoglobulin G 1, anti-(human interleukin 2 receptor) (human-mouse monoclonal CHI621 γ1-chain), disulfide with human-mouse monoclonal CHI621 light chain, dimer (WHO )

Foreign Names

  • Basiliximabum (Latin)
  • Basiliximab (German)
  • Basiliximab (French)
  • Basiliximab (Spanish)

Generic Names

Brand Names

  • Simulect
    Al Masria, Egypt; Novartis, Argentina; Novartis, Belgium; Novartis, Brazil; Novartis, Chile; Novartis, China; Novartis, Czech Republic; Novartis, Denmark; Novartis, Ecuador; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Iceland; Novartis, Japan; Novartis, South Korea; Novartis, Lebanon; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Sweden; Novartis, Slovakia; Novartis, Thailand; Novartis, Tunisia; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis, Vietnam; Novartis AH, South Africa; Novartis Europharm, Greece; Novartis Europharm Limited, Latvia; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis Healthcare, Philippines; Novartis Pharma, Switzerland; Novartis Pharma, Germany; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom; Novartis, Lithuania

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide